Biophytis SA
PAR:ALBPS

Watchlist Manager
Biophytis SA Logo
Biophytis SA
PAR:ALBPS
Watchlist
Price: 0.0801 EUR 0.13%
Market Cap: 3.2m EUR

Relative Value

There is not enough data to reliably calculate the relative value of ALBPS.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALBPS Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
Forward
2.1
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-16.7
Industry
23.7
Forward
-0.2
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-19.3
Industry
22
vs History
vs Industry
Median 3Y
-3
Median 5Y
-18.2
Industry
23.8
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-0.9
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.3
Forward
3.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.1
vs History
vs Industry
28
Median 3Y
-1.9
Median 5Y
-18.7
Industry
6.4
Forward
-0.6
vs History
vs Industry
26
Median 3Y
-1.8
Median 5Y
-18.1
Industry
7
Forward
-0.5
vs History
vs Industry
30
Median 3Y
-2
Median 5Y
-19.2
Industry
8.3
vs History
vs Industry
26
Median 3Y
-2
Median 5Y
-18.9
Industry
6.5
vs History
88
vs Industry
53
Median 3Y
17.7
Median 5Y
94.9
Industry
5.7

Multiples Across Competitors

ALBPS Competitors Multiples
Biophytis SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Biophytis SA
PAR:ALBPS
3.2m EUR 0 -0.4 -0.6 -0.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 809 907.8 -160 693.5 -195 133.1 -192 906.4
US
Abbvie Inc
NYSE:ABBV
394.7B USD 6.6 168.1 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.9B USD 4.8 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
148.6B USD 5.1 18.3 12.3 12.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 083.7 -531.7 -579 -563.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD 5.5 17.1 16.2 18.4
AU
CSL Ltd
ASX:CSL
86.8B AUD 3.7 19.2 12.9 16.1
NL
argenx SE
XBRU:ARGX
42.1B EUR 13.7 32.2 55.3 56.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 202.7 158 191.6
P/S Multiple
Revenue Growth P/S to Growth
FR
Biophytis SA
PAR:ALBPS
Average P/S: 3 381 205.7
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 809 907.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
10%
1
US
E
Epizyme Inc
F:EPE
2 083.7
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
NL
argenx SE
XBRU:ARGX
13.7
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.3
46%
0.4
P/E Multiple
Earnings Growth PEG
FR
Biophytis SA
PAR:ALBPS
Average P/E: 189.2
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 693.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
9%
1.9
AU
CSL Ltd
ASX:CSL
19.2
11%
1.7
NL
argenx SE
XBRU:ARGX
32.2
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 202.7
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Biophytis SA
PAR:ALBPS
Average EV/EBITDA: 39
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 133.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
12.9
8%
1.6
NL
argenx SE
XBRU:ARGX
55.3
839%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Biophytis SA
PAR:ALBPS
Average EV/EBIT: 45
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 906.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
16.1
11%
1.5
NL
argenx SE
XBRU:ARGX
56.8
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.6
N/A N/A